CTNM - CIK 0001855175
The table below shows Contineum Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $20.16M | $42.63M | $20.78M | $22.47M | $40.89M | $77.23M |
| Short-term investments | $226.17M | $139.77M | $154.70M | $168.24M | $173.02M | $141.42M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $252.96M |
| $184.93M |
| $176.84M |
| $192.13M |
| $215.14M |
| $220.32M |
| Property, plant & equipment | $1.06M | $880.00K | $856.00K | $891.00K | $888.00K | $801.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $261.35M | $190.85M | $182.89M | $198.26M | $216.03M | $221.35M |
| Accounts payable | $1.50M | $786.00K | $2.00M | $3.65M | $1.40M | $734.00K |
| Total current liabilities | $6.66M | $6.36M | $7.21M | $8.95M | $5.81M | $3.74M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $11.31M | $10.38M | $11.50M | $13.50M | $5.81M | $3.85M |
| Retained earnings | -$191.84M | -$162.22M | -$149.43M | -$133.39M | -$102.84M | -$92.57M |
| Total equity | $250.04M | $180.47M | $171.39M | $184.77M | $210.23M | $217.50M |